- Expensive MS drug to be on PBS next year 9news.com.au
- 'Previously unaffordably' MS drug to be listed on PBS SBS News
- Multiple sclerosis patients to save $54,000 a year after Mavenclad medication listed on PBS ABC News
- Multiple sclerosis drug Mavenclad to be heavily subsidised in the new year under PBS The Advertiser
- 'Previously unaffordable' MS drug to be listed on PBS SBS News
- View full coverage on Google News
